Bristol-Myers Squibb Co (NYSE:BMY)

55.95
BATS BZX Real-Time Price
As of 2:00pm ET
 -0.53 / -0.94%
Today’s Change
42.48
Today|||52-Week Range
59.18
+7.64%
Year-to-Date
Why Celgene's Latest FDA Approval Makes Bristol-Myers Squibb's Dividend Look Even Better
Nov 12 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen vs. Celgene
Nov 10 / MotleyFool.com - Paid Partner Content
Why Bristol-Myers Squibb Stock Gained 13% in October
Nov 11 / MotleyFool.com - Paid Partner Content
How Sweet Were Nektar Therapeutics' Q3 Results?
Nov 07 / MotleyFool.com - Paid Partner Content